Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Emerg Microbes Infect ; 4(12): e77, 2015 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-26714783

RESUMEN

Campylobacter jejuni is the most prevalent cause of bacterial gastroenteritis worldwide. Polyphosphate kinases 1 and 2 (PPK1 and PPK2) regulate several cellular processes, including the biosynthesis of the bacterial cell wall. Despite their importance, whether PPK1 and PPK2 modulate the composition of C. jejuni outer membrane constituents (OMCs) and consequently impact its interaction with host cells remains unknown. Our comparative analysis between C. jejuni wild type, Δppk1, and Δppk2 strains showed qualitative and quantitative differences in the total OMC composition among these strains. Importantly, these OMC variations observed on the C. jejuni polyphosphate kinase mutants are directly related to their capacity to invade, survive, and alter the immune response of intestinal epithelial cells in vitro. Specifically, sub-fractionation of the C. jejuni OMC indicated that OMC proteins are uniquely associated with bacterial invasion, whereas C. jejuni OMC proteins, lipids, and lipoglycans are all associated with C. jejuni intracellular survival. This study provides new insights regarding the function of polyphosphate kinases and their role in C. jejuni infection.


Asunto(s)
Antiinfecciosos/farmacología , Infecciones por Campylobacter/microbiología , Campylobacter jejuni/citología , Campylobacter jejuni/patogenicidad , Células Epiteliales/microbiología , Gastroenteritis/microbiología , Fosfotransferasas (Aceptor del Grupo Fosfato)/metabolismo , Infecciones por Campylobacter/tratamiento farmacológico , Campylobacter jejuni/efectos de los fármacos , Línea Celular , Células Epiteliales/efectos de los fármacos , Gastroenteritis/tratamiento farmacológico , Humanos , Técnicas In Vitro , Interleucina-8/metabolismo , Terapia Molecular Dirigida/tendencias , Fosfotransferasas (Aceptor del Grupo Fosfato)/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...